{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:59:28Z","timestamp":1792166368673,"version":"4.4.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Circular RNAs (circRNAs) play crucial roles in the development and progression of human cancers, including non-small cell lung cancer (NSCLC). However, most of these circRNAs, such as hsa_circ_0014235, are not fully identified in functions and mechanisms.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>The isolated exosomes from serum specimens were identified using transmission electron microscopy (TEM). The expression of hsa_circ_0014235, miR-520a-5p and cyclin-dependent kinase 4 (CDK4) was detected by real-time quantitative polymerase chain reaction (qPCR). For functional assays, cell proliferation, colony formation ability, migration, invasion, cell apoptosis and cell cycle progression were determined using cell counting kit-8 (CCK-8) assay, colony formation assay, wound healing assay, transwell assay and flow cytometry assay, respectively. The expression of CDK4 and other indicated marker proteins was detected by western blot. The predicted target relationship between miR-520a-5p and hsa_circ_0014235 or cyclin-dependent kinase 4 (CDK4) was verified by dual-luciferase reporter assay or RNA immunoprecipitation (RIP) assay.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The expression of hsa_circ_0014235 was notably elevated in NSCLC serum-derived exosomes, tumor tissues and cells. NSCLC serum-derived exosomes promoted NSCLC cell resistance to cisplatin (DDP), cell proliferation, migration and invasion in vitro, as well as tumor growth and DDP resistance in vivo. Hsa_circ_0014235 overexpression enhanced DDP resistance and facilitated cell malignant behaviors. MiR-520a-5p was a target of hsa_circ_0014235, and rescue experiments showed that miR-520a-5p restoration reversed the effects of hsa_circ_0014235 overexpression. Moreover, CDK4 was a target of miR-520a-5p, and rescue experiments showed that CDK4 knockdown reversed the aggressive effects of miR-520a-5p inhibition on NSCLC progression.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Exosome-transmitted hsa_circ_0014235 promoted NSCLC malignant development by mediating the miR-520a-5p\/CDK4 regulatory axis.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12935-020-01642-9","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T18:02:58Z","timestamp":1605636178000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Exosome-transferred hsa_circ_0014235 promotes DDP chemoresistance and deteriorates the development of non-small cell lung cancer by mediating the miR-520a-5p\/CDK4 pathway"],"prefix":"10.1186","volume":"20","author":[{"given":"Xueliang","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9730-7030","authenticated-orcid":false,"given":"Xia","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,17]]},"reference":[{"issue":"1","key":"1642_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics. CA J Clin. 2017;67(1):7\u201330.","journal-title":"CA J Clin."},{"key":"1642_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3389\/fonc.2018.00267","volume":"8","author":"V Sosa Iglesias","year":"2018","unstructured":"Sosa Iglesias V, Giuranno L, Dubois LJ, Theys J, Vooijs M. Drug resistance in non-small cell lung cancer: a potential for NOTCH targeting? Front Oncol. 2018;8:267.","journal-title":"Front Oncol."},{"issue":"10","key":"1642_CR3","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1158\/1078-0432.CCR-14-2748","volume":"21","author":"K Politi","year":"2015","unstructured":"Politi K, Herbst RS. Lung cancer in the era of precision medicine. Clinical cancer research: an official journal of the American Association for Cancer Research. 2015;21(10):2213\u201320.","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"issue":"3","key":"1642_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11912-019-0770-x","volume":"21","author":"PR Halliday","year":"2019","unstructured":"Halliday PR, Blakely CM, Bivona TG. Emerging targeted therapies for the treatment of non-small cell lung cancer. Current oncology reports. 2019;21(3):21.","journal-title":"Current oncology reports"},{"key":"1642_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41392-019-0099-9","volume":"4","author":"M Yuan","year":"2019","unstructured":"Yuan M, Huang LL, Chen JH, Wu J, Xu Q. The emerging treatment landscape of targeted therapy in non-small-cell lung cancer. Signal Trans Target Ther. 2019;4:61.","journal-title":"Signal Trans Target Ther"},{"issue":"8","key":"1642_CR6","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nri855","volume":"2","author":"C Thery","year":"2002","unstructured":"Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Revi Immunol. 2002;2(8):569\u201379.","journal-title":"Nat Revi Immunol"},{"issue":"3","key":"1642_CR7","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1586\/epr.09.17","volume":"6","author":"RJ Simpson","year":"2009","unstructured":"Simpson RJ, Lim JW, Moritz RL, Mathivanan S. Exosomes: proteomic insights and diagnostic potential. Expert Rev Proteomics. 2009;6(3):267\u201383.","journal-title":"Expert Rev Proteomics"},{"issue":"3","key":"1642_CR8","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.4049\/jimmunol.179.3.1969","volume":"179","author":"C Admyre","year":"2007","unstructured":"Admyre C, Johansson SM, Qazi KR, Filen JJ, Lahesmaa R, Norman M, Neve EP, Scheynius A, Gabrielsson S. Exosomes with immune modulatory features are present in human breast milk. J Immunol. 2007;179(3):1969\u201378.","journal-title":"J Immunol"},{"issue":"5","key":"1642_CR9","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1111\/jvim.12128","volume":"27","author":"JM Herring","year":"2013","unstructured":"Herring JM, McMichael MA, Smith SA. Microparticles in health and disease. J Vet Intern Med. 2013;27(5):1020\u201333.","journal-title":"J Vet Intern Med"},{"key":"1642_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/ijms18010003","volume":"18","author":"MHR Bayraktar","year":"2017","unstructured":"Bayraktar MHR, Abd-Ellah EGKH, Amero MF, Chavez-Reyes P, Rodriguez-Aguayo AC. Exosomes: from garbage bins to promising therapeutic targets. Int J Mol Sci. 2017;18:3.","journal-title":"Int J Mol Sci."},{"issue":"1","key":"1642_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ygyno.2008.04.033","volume":"110","author":"DD Taylor","year":"2008","unstructured":"Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol. 2008;110(1):13\u201321.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"1642_CR12","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1007\/s13277-014-2807-y","volume":"36","author":"Q Li","year":"2015","unstructured":"Li Q, Shao Y, Zhang X, Zheng T, Miao M, Qin L, Wang B, Ye G, Xiao B, Guo J. Plasma long noncoding RNA protected by exosomes as a potential stable biomarker for gastric cancer. Tumour Biol. 2015;36(3):2007\u201312.","journal-title":"Tumour Biol"},{"key":"1642_CR13","first-page":"85","volume":"12","author":"J Xian","year":"2020","unstructured":"Xian J, Su W, Liu L, Rao B, Lin M, Feng Y, Qiu F, Chen J, Zhou Q, Zhao Z, et al. Identification of three circular RNA cargoes in serum exosomes as diagnostic biomarkers of non-small-cell lung cancer in the Chinese population. J Mol Diagn. 2020;12:85.","journal-title":"J Mol Diagn"},{"issue":"4","key":"1642_CR14","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/15476286.2015.1020271","volume":"12","author":"LL Chen","year":"2015","unstructured":"Chen LL, Yang L. Regulation of circRNA biogenesis. RNA Biol. 2015;12(4):381\u20138.","journal-title":"RNA Biol"},{"issue":"24","key":"1642_CR15","first-page":"8712","volume":"22","author":"B Yan","year":"2018","unstructured":"Yan B, Zhang W, Mao XW, Jiang LY. Circular RNA ciRS-7 correlates with advance disease and poor prognosis, and its down-regulation inhibits cells proliferation while induces cells apoptosis in non-small cell lung cancer. Eur Rev Med Pharmacol Sci. 2018;22(24):8712\u201321.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"1642_CR16","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-018-0887-9","volume":"17","author":"S Tan","year":"2018","unstructured":"Tan S, Sun D, Pu W, Gou Q, Guo C, Gong Y, Li J, Wei YQ, Liu L, Zhao Y, et al. Circular RNA F-circEA-2a derived from EML4-ALK fusion gene promotes cell migration and invasion in non-small cell lung cancer. Mol Cancer. 2018;17(1):138.","journal-title":"Mol Cancer"},{"issue":"1","key":"1642_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12943-019-0943-0","volume":"18","author":"L Chen","year":"2019","unstructured":"Chen L, Nan A, Zhang N, Jia Y, Li X, Ling Y, Dai J, Zhang S, Yang Q, Yi Y, et al. Circular RNA 100146 functions as an oncogene through direct binding to miR-361-3p and miR-615-5p in non-small cell lung cancer. Mol Cancer. 2019;18(1):13.","journal-title":"Mol Cancer"},{"issue":"8","key":"1642_CR18","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/cr.2015.82","volume":"25","author":"Y Li","year":"2015","unstructured":"Li Y, Zheng Q, Bao C, Li S, Guo W, Zhao J, Chen D, Gu J, He X, Huang S. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res. 2015;25(8):981\u20134.","journal-title":"Cell Res"},{"key":"1642_CR19","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.canlet.2018.04.035","volume":"432","author":"Z Li","year":"2018","unstructured":"Li Z, Yanfang W, Li J, Jiang P, Peng T, Chen K, Zhao X, Zhang Y, Zhen P, Zhu J, et al. Tumor-released exosomal circular RNA PDE8A promotes invasive growth via the miR-338\/MACC1\/MET pathway in pancreatic cancer. Cancer Lett. 2018;432:237\u201350.","journal-title":"Cancer Lett"},{"key":"1642_CR20","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.2147\/OTT.S235664","volume":"13","author":"L Liang","year":"2020","unstructured":"Liang L, Zhang L, Zhang J, Bai S, Fu H. Identification of circRNA-miRNA-mRNA networks for exploring the fundamental mechanism in lung adenocarcinoma. OncoTargets Therapy. 2020;13:2945\u201355.","journal-title":"OncoTargets Therapy"},{"issue":"1","key":"1642_CR21","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12967-018-1582-8","volume":"16","author":"J Cheng","year":"2018","unstructured":"Cheng J, Zhuo H, Xu M, Wang L, Xu H, Peng J, Hou J, Lin L, Cai J. Regulatory network of circRNA-miRNA-mRNA contributes to the histological classification and disease progression in gastric cancer. J Transl Med. 2018;16(1):216.","journal-title":"J Transl Med"},{"issue":"4","key":"1642_CR22","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/1878-0261.12468","volume":"13","author":"L Verduci","year":"2019","unstructured":"Verduci L, Strano S, Yarden Y, Blandino G. The circRNA-microRNA code: emerging implications for cancer diagnosis and treatment. Mol Oncol. 2019;13(4):669\u201380.","journal-title":"Mol Oncol"},{"issue":"2","key":"1642_CR23","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nsmb.1552","volume":"16","author":"S Gu","year":"2009","unstructured":"Gu S, Jin L, Zhang F, Sarnow P, Kay MA. Biological basis for restriction of microRNA targets to the 3\u2019 untranslated region in mammalian mRNAs. Nat Struct Mol Biol. 2009;16(2):144\u201350.","journal-title":"Nat Struct Mol Biol"},{"issue":"4","key":"1642_CR24","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1053\/j.semdp.2014.06.008","volume":"31","author":"J Fujimoto","year":"2014","unstructured":"Fujimoto J, Wistuba II. Current concepts on the molecular pathology of non-small cell lung carcinoma. Semin Diagn Pathol. 2014;31(4):306\u201313.","journal-title":"Semin Diagn Pathol"},{"issue":"9","key":"1642_CR25","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nrclinonc.2017.14","volume":"14","author":"G Siravegna","year":"2017","unstructured":"Siravegna G, Marsoni S, Siena S, Bardelli A. Integrating liquid biopsies into the management of cancer. Nat Rev Clin Oncol. 2017;14(9):531\u201348.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"1642_CR26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1373\/clinchem.2014.230433","volume":"61","author":"JH Bahn","year":"2015","unstructured":"Bahn JH, Zhang Q, Li F, Chan TM, Lin X, Kim Y, Wong DT, Xiao X. The landscape of microRNA, Piwi-interacting RNA, and circular RNA in human saliva. Clin Chem. 2015;61(1):221\u201330.","journal-title":"Clin Chem"},{"issue":"10","key":"1642_CR27","doi-asserted-by":"publisher","first-page":"e0141214","DOI":"10.1371\/journal.pone.0141214","volume":"10","author":"S Memczak","year":"2015","unstructured":"Memczak S, Papavasileiou P, Peters O, Rajewsky N. Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood. PloS ONE. 2015;10(10):e0141214.","journal-title":"PloS ONE"},{"issue":"4","key":"1642_CR28","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1158\/1078-0432.CCR-18-1447","volume":"25","author":"L Li","year":"2019","unstructured":"Li L, Li W, Chen N, Zhao H, Xu G, Zhao Y, Pan X, Zhang X, Zhou L, Yu D, et al. FLI1 exonic circular RNAs as a novel oncogenic driver to promote tumor metastasis in small cell lung cancer. Clin Cancer Res. 2019;25(4):1302\u201317.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"1642_CR29","doi-asserted-by":"publisher","first-page":"8733","DOI":"10.1007\/s13277-014-2138-z","volume":"35","author":"BT Kaymaz","year":"2014","unstructured":"Kaymaz BT, Cetintas VB, Aktan C, Kosova B. MicroRNA-520a-5p displays a therapeutic effect upon chronic myelogenous leukemia cells by targeting STAT3 and enhances the anticarcinogenic role of capsaicin. Tumour Biol. 2014;35(9):8733\u201342.","journal-title":"Tumour Biol"},{"key":"1642_CR30","first-page":"65","volume":"24","author":"X Liu","year":"2020","unstructured":"Liu X, Song J, Kang Y, Wang Y, Chen A. Long noncoding RNA SOX21-AS1 regulates the progression of triple-negative breast cancer through regulation of miR-520a-5p\/ORMDL3 axis. J Cell Biochem. 2020;24:65.","journal-title":"J Cell Biochem."},{"key":"1642_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.18632\/aging.102228","volume":"12","author":"M Jin","year":"2020","unstructured":"Jin M, Shi C, Hua Q, Li T, Yang C, Wu Y, Zhao L, Yang H, Zhang J, Hu C, et al. High circ-SEC31A expression predicts unfavorable prognoses in non-small cell lung cancer by regulating the miR-520a-5p\/GOT-2 axis. Aging. 2020;12:35.","journal-title":"Aging."},{"key":"1642_CR32","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1479-5876-9-38","volume":"9","author":"A Wu","year":"2011","unstructured":"Wu A, Wu B, Guo J, Luo W, Wu D, Yang H, Zhen Y, Yu X, Wang H, Zhou Y, et al. Elevated expression of CDK4 in lung cancer. J Transl Med. 2011;9:38.","journal-title":"J Transl Med"},{"issue":"2","key":"1642_CR33","doi-asserted-by":"publisher","first-page":"e88022","DOI":"10.1371\/journal.pone.0088022","volume":"9","author":"B Du","year":"2014","unstructured":"Du B, Wang Z, Zhang X, Feng S, Wang G, He J, Zhang B. MicroRNA-545 suppresses cell proliferation by targeting cyclin D1 and CDK4 in lung cancer cells. PloS ONE. 2014;9(2):e88022.","journal-title":"PloS ONE"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-020-01642-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12935-020-01642-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-020-01642-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T18:08:10Z","timestamp":1605636490000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-020-01642-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,17]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1642"],"URL":"https:\/\/doi.org\/10.1186\/s12935-020-01642-9","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,17]]},"assertion":[{"value":"30 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no financial conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"552"}}